Tribunal grants cenvat credit for clean room items, crucial for pharmaceutical manufacturing. The Tribunal allowed the appellant's appeal, holding that the items used to create a clean room were eligible for cenvat credit as inputs essential for ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tribunal grants cenvat credit for clean room items, crucial for pharmaceutical manufacturing.
The Tribunal allowed the appellant's appeal, holding that the items used to create a clean room were eligible for cenvat credit as inputs essential for pharmaceutical manufacturing. The Tribunal emphasized the importance of the clean room in maintaining suitable conditions for production and interpreted the definition of 'inputs' under Rule 2(k) of CCR broadly to include all goods used in the manufacturing process. As a result, the decision disallowing the credit was overturned, granting the appellant the entitlement to the credit and associated benefits under the law.
Issues: 1. Eligibility of cenvat credit on items used for creating a clean room. 2. Interpretation of the definition of 'input' under Rule 2(k) of CCR, 2004.
Analysis: Issue 1: The appellant, engaged in manufacturing pharmaceuticals, purchased various items to create a clean room for maintaining temperature and RH control essential for pharmaceutical production. Revenue disallowed cenvat credit on these items, considering them neither capital goods nor inputs. The show cause notice proposed disallowance of credit and penalty, which was confirmed in the order-in-original. The Commissioner (Appeals) upheld the decision, leading to the appellant's appeal before the Tribunal.
Issue 2: The appellant argued that the items in dispute were used as inputs for fabricating the clean room, essential for manufacturing pharmaceuticals. Referring to Rule 2(k) of CCR defining 'input' as all goods used in the manufacturer's factory, the appellant contended that the credit should be allowed as inputs. The Revenue, however, relied on a previous Tribunal ruling that clean rooms cannot be considered capital goods or their components for credit eligibility.
The Tribunal, after considering the contentions, found that the clean room was crucial for maintaining proper conditions necessary for pharmaceutical production. Recognizing the definition of 'inputs' under Rule 2(k) of CCR as all goods used in the factory for manufacturing final products, the Tribunal held that the appellant was entitled to cenvat credit on the disputed items as inputs. Consequently, the impugned order disallowing the credit was set aside, and the appeal was allowed, granting the appellant consequential benefits as per the law.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.